APA (7th ed.) Citation

Kanellopoulos, P., Mattsson, A., Abouzayed, A., Obeid, K., Nock, B. A., Tolmachev, V., . . . Orlova, A. (2024). Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology. EJNMMI Radiopharmacy & Chemistry, 1. https://doi.org/10.1186/s41181-024-00242-6

Chicago Style (17th ed.) Citation

Kanellopoulos, Panagiotis, Adam Mattsson, Ayman Abouzayed, Karim Obeid, Berthold A. Nock, Vladimir Tolmachev, Theodosia Maina, and Anna Orlova. "Preclinical Evaluation of New GRPR-antagonists with Improved Metabolic Stability for Radiotheranostic Use in Oncology." EJNMMI Radiopharmacy & Chemistry 2024: 1. https://doi.org/10.1186/s41181-024-00242-6.

MLA (9th ed.) Citation

Kanellopoulos, Panagiotis, et al. "Preclinical Evaluation of New GRPR-antagonists with Improved Metabolic Stability for Radiotheranostic Use in Oncology." EJNMMI Radiopharmacy & Chemistry, 2024, p. 1, https://doi.org/10.1186/s41181-024-00242-6.